PCOS new name: A common hormonal condition affecting an estimated one in eight women worldwide, has been renamed, with experts hoping the change will lead to better understanding, earlier diagnosis and more complete care.
Polycystic ovary syndrome, widely known as PCOS, will now be called polyendocrine metabolic ovarian syndrome, or PMOS. The change follows years of work by researchers, clinicians and patient groups, and was published in The Lancet.
Also Read | Can naturopathy help PCOS? Natural solutions for irregular periods, and acne
Experts say the old name was misleading because it placed too much emphasis on the ovaries and “cysts,” even though the condition is broader and involves hormonal, metabolic and reproductive health. PMOS can affect menstrual cycles, skin, weight, fertility, mental health and long-term metabolic risk.
Symptoms can vary widely. Some people may experience irregular periods, acne, excess facial or body hair, hair thinning or difficulty conceiving. Doctors say this variation is one reason the condition is often missed or diagnosed late.
The condition has also been linked with metabolic syndrome, which can raise the risk of type 2 diabetes, heart disease and stroke. Treatment usually depends on the patient’s symptoms and goals, and may include lifestyle changes, insulin-sensitising medication, hormonal treatment or fertility-focused care.
The name change is not just cosmetic. Supporters say calling it PMOS reflects the condition more accurately and may help patients receive care that looks beyond periods and ovaries to the full-body impact of the disorder.
